Liney G P, Turnbull L W, Knowles A J
Department of Medical Physics, The University of Hull, UK.
NMR Biomed. 1999 Feb;12(1):39-44. doi: 10.1002/(sici)1099-1492(199902)12:1<39::aid-nbm543>3.0.co;2-1.
The quantitation of in vivo 1H MR spectroscopy and dynamic contrast enhanced MR imaging is described for patients with histologically confirmed prostate adenocarcinoma and benign prostatic hypertrophy (BPH). Results are presented which suggest that combined use of these techniques may be helpful in improving the characterization of prostate pathologies and ultimately increase the staging accuracy of magnetic resonance.
本文描述了对组织学确诊为前列腺腺癌和良性前列腺增生（BPH）患者的体内氢质子磁共振波谱定量分析及动态对比增强磁共振成像。所呈现的结果表明，联合使用这些技术可能有助于改善前列腺病变的特征描述，并最终提高磁共振成像的分期准确性。
